These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2514517)

  • 1. Glutaraldehyde in whole-cell Bordetella pertussis vaccine.
    Arya SC; Ashraf SJ; Pathak VP
    Vaccine; 1989 Dec; 7(6):486. PubMed ID: 2514517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on pertussis vaccine batches inactivated with glutaraldehyde, beta-propiolactone, formaldehyde or thiomersal.
    Andreescu V; Caffé I; Marion M; Ivan I; David C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):299-308. PubMed ID: 122592
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detoxification of Bordetella pertussis organisms or pertussis toxin with glutaraldehyde for preparation of pertussis vaccine.
    Gupta RK
    Vaccine; 1991 Sep; 9(9):690-1. PubMed ID: 1950101
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and detoxification of an easily prepared acellular pertussis vaccine. Antigenic role of the A protomer of pertussis toxin.
    García-Sáinz JA; Romero-Avila MT; Ruíz-Arriaga A; Ruíz-Puente J; Agundis C; Ortiz V; Isibasi A
    Vaccine; 1992; 10(5):341-4. PubMed ID: 1574919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modified leukocytosis promoting factor (LPF)-test: a valuable supplement to the mouse weight gain (MWG)-test in toxicity control of whole cell pertussis vaccine.
    van Straaten-van de Kappelle I; Wiertz EJ; Marsman FR; Borsboom DJ; van de Donk HJ; Kreeftenberg JG
    Biologicals; 1992 Dec; 20(4):277-82. PubMed ID: 1305404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation.
    García-Sánz JA; Ruiz-Puente J; Jiménez-Paredes J; González-Pacheco M; Villalva-Posada H
    Vaccine; 1985 Mar; 3(1):23-6. PubMed ID: 4039870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
    Horiuchi Y; Takahashi M; Asada S; Ishida S
    Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis.
    Mohammadpour Dounighi N; Razzaghi-Abyane M; Nofeli M; Zolfagharian H; Shahcheraghi F
    Jundishapur J Microbiol; 2016 Jul; 9(7):e34153. PubMed ID: 27679704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of elevated temperatures on the opacity and toxicity of pertussis vaccines manufactured with different inactivating agents.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1986 Sep; 4(3):185-90. PubMed ID: 3094265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity testing of pertussis vaccines: effect of increased sensitivity of mice to Bordetella pertussis.
    Cameron J; Desormeaux Y; De Bellefeuille ML; Leclerc J
    J Biol Stand; 1984 Jan; 12(1):19-24. PubMed ID: 6321509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine.
    van Straaten-van de Kappelle I; van der Gun JW; Marsman FR; Hendriksen CF; van de Donk HJ
    Biologicals; 1997 Mar; 25(1):41-57. PubMed ID: 9167008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.